Arteris, Inc. (NASDAQ:AIP – Get Free Report) VP Paul Alpern sold 3,648 shares of the firm’s stock in a transaction on Thursday, July 2nd. The stock was sold at an average price of $38.78, for a total value of $141,469.44. Following the transaction, the vice president owned 76,736 shares of the company’s stock, valued at approximately $2,975,822.08. This represents a 4.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Arteris Trading Down 0.7%
Shares of AIP stock traded down $0.24 on Monday, hitting $34.82. The stock had a trading volume of 1,091,305 shares, compared to its average volume of 747,970. The company’s 50 day moving average price is $36.32 and its 200-day moving average price is $23.54. Arteris, Inc. has a 1 year low of $8.42 and a 1 year high of $50.26. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.73 and a quick ratio of 0.73. The firm has a market capitalization of $1.61 billion, a P/E ratio of -44.08 and a beta of 1.92.
Arteris (NASDAQ:AIP – Get Free Report) last released its earnings results on Tuesday, May 12th. The company reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.05. The firm had revenue of $22.94 million during the quarter, compared to analyst estimates of $21.03 million. Analysts anticipate that Arteris, Inc. will post -0.54 earnings per share for the current year.
Institutional Investors Weigh In On Arteris
Analyst Ratings Changes
AIP has been the subject of several research reports. Northland Securities set a $38.00 price target on shares of Arteris in a research note on Wednesday, May 13th. TD Cowen boosted their target price on Arteris from $22.00 to $40.00 and gave the stock a “buy” rating in a research note on Wednesday, May 13th. Wall Street Zen cut shares of Arteris from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Weiss Ratings cut shares of Arteris from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 13th. Finally, Rosenblatt Securities increased their target price on Arteris from $20.00 to $38.00 and gave the company a “buy” rating in a report on Wednesday, May 13th. Two equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $37.75.
About Arteris
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
See Also
- Five stocks we like better than Arteris
- Flash Crash or Cash? The AI Hardware Reset Investors Can’t Ignore
- As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner
- KBR Insiders Are Buying While the Market Misreads Its Spinoff
- Contrarian Alert: 5 Downgraded Stocks That May Reward Long-Term Investors
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
